Clinical Effects of Natalizumab on Multiple Sclerosis Appear Early in Treatment Course

Journal of Neurology - Germany
doi 10.1007/s00415-012-6809-7
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Natalizumab Treatment in Multiple Sclerosis

Clinical Neurology
Neurology
2015English

Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2018English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Journal of Neurology & Neurophysiology
2015English

Impact of Mast Cells on Multiple Sclerosis: Inhibitory Effect of Natalizumab

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2014English

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

JAMA Neurology
Neurology
2013English

Alemtuzumab Following Natalizumab in Highly Active Paediatric-Onset Multiple Sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2019English

Evolution of MRI Appearances Due to Progressive Multifocal Leucoencephalopathy Following Natalizumab Treatment for Multiple Sclerosis

BMJ Case Reports
Medicine
2015English

Intrathecal Effects of Daclizumab Treatment of Multiple Sclerosis

Neurology
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy